• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

DDI Webinar - Bad Ad - April 16, 2013

The Food and Drug Administration, Center for Drug Evaluation and Research (CDER), is delighted to inform you of a unique opportunity for healthcare professionals, pharmacy students, nurse practitioner students and medical students in the United States to learn more about the FDA and drug regulation. CDER's Division of Drug Information (DDI) is offering a series of educational webinars, developed by FDA pharmacists and targeted to the needs of all healthcare professionals and students.

 
These focused webinars support FDA's mission of promoting and protecting public health, through interaction and education to strengthen relationships with future clinicians, researchers, nurses, and pharmacists. Fostering this connection will provide a better understanding of FDA's role in public health as a regulatory agency.
 
On April 16, 2013, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled, "Overview of Bad Ad Program: How to Recognize and Report Misleading Promotion". The featured speaker, LCDR Adora Ndu, Pharm.D., Regulatory Review Officer in CDER's Office of Prescription Drug Promotion (OPDP) gave an overview of the program, including an overview of prescription drug promotion violations and how healthcare professionals can report suspected misleading prescription drug promotion to the FDA.
-

Presentation Information

There were 2 TV Spots used in the presentation that did not come thru at the time the webinar was given. They are included below with the time of the presentation notated that they would have run.

-
Adobe, the Adobe logo, Acrobat and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.